Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

12 Results

Guidelines and Advice

Models of Care for Cancer Survivorship

Status: Current
ID: 26-1
Version: 2

Mar 2017

Guidelines and Advice

Use of 5-HT3 Receptor Antagonists in Patients Receiving Moderately or Highly Emetogenic Chemotherapy

Status: Archived
ID: 12-3

Jan 2003

Guidelines and Advice

Radiotherapy Fractionation for the Palliation of Uncomplicated Painful Bone Metastases

Status: Archived
ID: 13-2

Mar 2003

Guidelines and Advice

The Treatment of Lymphedema Related to Breast Cancer

Status: Archived
ID: 13-1

Aug 2003

Guidelines and Advice

Hyperfractionated Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Status: Archived
ID: 5-6b

Jan 2003

Statistical Reports

Cancer in First Nations in Ontario: Risk Factors and Screening Report

Mar 2017

Statistical Reports

News & Information on Nutrition & Cancer Prevention

Dec 2003

Statistical Reports

News & Information on Prostate Cancer

May 2003

Guidelines and Advice

Brachytherapy for Patients With Prostate Cancer: American Society of Clinical Oncology/Cancer Care Ontario Joint Guideline Update

Status: In-Review
ID: GL-3-A-2016-1

Mar 2017

Guidelines and Advice

Complex Malignant Hematology Models of Care: Recommendations for Changes in the Roles and Composition of the Multidisciplinary Team and the Setting of Care to Improve Access for Patients in Ontario – March 2017

Status: Current
ID: GL-C50-31

Mar 2017

Regimen

CISPETOP(3D)

Cancer Type:

Unknown Primary

Show More Show more tags

, Show Less Show fewer tags

Intent: Palliative

Drugs Used:

... Show more tags

, Collapse Show fewer tags

Quick Link(s):

Regimen Monograph

Mar 2017

Cancer facts

Number of Colorectal Cancer Screening Tests Performed in Ontario Plateaued

Mar 2017